Polaris Biology

Luan Biosciences (Polaris biology) has developed a single-cell diagnostic platform for detection of tumors. The platform uses high-throughput single-cell analysis devices and artificial intelligence-based system biology models to achieve a personalized diagnosis of malignancies at the single cell level. The company operates in the Genomics sector with additional focus on Oncology and Clinical Genomics. Its business model centers on Pan Cancer. Founded in 2016, headquartered in Shanghai, China. The company has raised $18.2M at the Series B stage. Backed by investors including 5Y Capital, Emerging Technology Partners, Baidu Ventures, volcanis.com, Wuxi Xiecheng Enterprise Management and others. Other investors include Ascendin Fund, Delian Capital, Puhua Capital, Volcanics Venture, Shulan Hospital and others. The company's website can be found at polarisbiology.com.